|
Bioethic information and analysis newsletter |
|||
|
|
Previous Letter |
|
|
|
N°69 - September 2005 |
|||
| The Newsletter index | |||
|
|
Aborted embryos and foetuses: surgical waste? | ||
|
|
Foetuses and still-born babies: what becomes of them? | ||
|
|
Loosening of legal requirements for post-mortem extraction of organs and tissue | ||
|
|
Umbilical cord stem cells: reality and promises | ||
|
|
|||
|
The discovery of 351 foetuses and bodies of still-born babies in the mortuary of Saint Vincent de Paul Hospital this summer upset public opinion and even left the Minister of Health “very shocked.” Why? At a time when 220 000 foetuses are extracted from their mother’s womb each year, this event cannot fail to make us wonder about the status of dead foetuses and embryos.
Surgical waste?
A legal
framework for the use of embryos or aborted foetuses
Which method of
disposal? A November the 6th 1997 decree regulates the disposal of healthcare-related waste (both waste representing an infection hazard, and anatomic parts.) The decree specifies that, amongst those anatomic parts, any limbs, organs or organ-parts easily recognizable by a “non-specialist” must be cremated. Even though the law does not explicitly specify this point, remains of embryos and foetus less than 22 weeks old and weighing under 500 gr tend to be treated as hospital waste. Is the respect owed these “potential human beings” compatible with cremating or disinfecting them as if they were common domestic garbage?
What status for
pre-natal beings?
The NCCE’s
advisory report For more information, see: Dictionnaire permanent Bioéthique et Biotechnologies (Permanent Dictionary of Bioethics and Biotechnologies), « Statut du corps humain, de ses éléments et produits, » (Status of the human body, bodily parts and bodily fluids.) |
|||
|
The so-called scandal of the embryos and foetuses found in jars in Saint Vincent de Paul Hospital leads us to recall the legal framework concerning what is to be done with foetuses, still-born babies, and non-viable children.
The 30th
of November 2001 circular
Civil registration
Burial or cremation |
|
Loosening of legal requirements for post-mortem extraction of organs and tissue |
|
The law concerning the conditions for the extraction of organs and tissues was made more flexible over the summer, in the hope of raising the number of post-mortem extraction, and thus of usable organs for transplants.
State of persistent cardiac and respiratory
inactivity
All healthcare institutions
What definition for death? |
|
A promising future For Valérie Planat, a CNRS researcher who works with Louis Casteilla on adult stem cells extracted from adipose tissues, “this study sounds very interesting and extremely original. It is, to my knowledge, the first time that microgravity has ever been used to conduct research on stem cells. If the umbilical stem cells live up to their promises, it will be necessary to find donors whose tissues are compatible with the patients’ and increase the number of umbilical blood banks.” Umbilical cell banks: an international network In the United States, Congress passed in 2004 a law granting funding of $150 million to the development of those bio banks. In Italy, 15 umbilical blood banks are currently operating, and the Cordon Blood Bank, one of the largest in the world after those of New York and Düsseldorf, was founded in Milan in 1993. The GRACE (Group for the conservation and development of haematopoietic cells,) an international network enabling patients to find donors thanks to a computer-based archive system connected to marrow and placenta blood donor records all over the world was founded in 1995.
A reality
and some successful treatments
For Pr.
Giuseppe Leone, the head of Haematology Institute of the Catholic University
of Rome and in charge of the umbilical stem cell bank of the Gemelli
Polyclinic, “no patient has ever been cured using
embryonic stem cells; on the other hand, adult stem cells like those of the
umbilical cord have proved their efficiency in the field of bone marrow
transplant; for example, to treat thalassemic syndrome, for children
suffering from leukaemia and patients suffering from congenital
immunodeficiency, and in many cases, it possible to speak of a successful
treatment: for immunodeficiency, we reach a 70-80% rate of recovery, and for
leukaemia, one of about 35-40%.Today,
there is also hope for the discovery of a cardiopathy treatment, whereas
embryonic cells have never been used and have therefore never proved that
they have any sort of therapeutic utility. »
1 - Cell Proliferation, August the 18th, 2005 |
is a monthly newsletter,
distributed free of charge, and published by the Jérôme Lejeune Foundation.
Director of the Publication : Jean-Marie Le Méné - Editor in chief : Aude
Dugast
31 rue Galande - 75005 Paris - France - Tel : +33 (0)1.55.42.55.14 - ISSN
1638-198 X
contact@genethique.org
|
|
Subscribe today to weekly Press Review or monthly Newsletter, it's free! |
| Traduction by A.R-TRADUCTION |